MindImmune Therapeutics, a private company developing new treatments targeting the inflammatory drivers of neurodegenerative disease, today announced two major milestones: the closing of a $10.2 ...

Among the stocks screened for valuation changes, 11.5% saw increases of 10.0% or more—higher than last quarter’s 9.4% rate ...

From wellness events to having a more mindful Christmas, these experts weigh in on how to avoid social burnout ...

Luxury travel expert Annabelle Thorpe of 101 Holidays discovers how top luxury hotels are embracing the new wave of 21st ...

Objectives To identify caregiver burden profiles among informal caregivers of children and adolescents with type 1 diabetes and explore associated factors. Design A multicentre cross-sectional survey ...